Yamashita Shinichi, Ito Akihiro, Mitsuzuka Koji, Ioritani Naomasa, Ishidoya Shigeto, Ikeda Yoshihiro, Numahata Kenji, Orikasa Kazuhiko, Tochigi Tatsuo, Soma Fumihiko, Namima Takashige, Arai Yoichi
Department of Urology, Tohoku University Graduate School of Medicine, Sendai.
Department of Urology, Japan Community Health Care Organization Sendai Hospital, Sendai.
Jpn J Clin Oncol. 2017 Sep 1;47(9):870-875. doi: 10.1093/jjco/hyx085.
The rate of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma is high. Seeding upper urinary tract urothelial carcinoma cells onto the damaged bladder wall is considered to be one of the causes of intravesical recurrence after radical nephroureterectomy. We evaluated the utility of early ureteral ligation in preventing the intravesical recurrence.
This prospective single-arm clinical trial included patients who underwent radical nephroureterectomy for upper urinary tract urothelial carcinoma in the Tohoku Urological Evidence-Based Medicine Study Group between 2012 and 2013. Early ureteral ligation was defined as ligation of the ureter as quickly as possible after expanding the retroperitoneal space. A historical control was extracted from 454 patients who underwent radical nephroureterectomy in the same group, using propensity score-matched analysis. Intravesical recurrence-free survival rates were analyzed using Kaplan-Meier curves. Factors predicting intravesical recurrence were assessed using multivariate analyses.
Seventy-four patients underwent early ureteral ligation. Seventeen (23%) patients had intravesical recurrence with a median follow-up period of 24 months. The 1- and 2-year intravesical recurrence-free survival rates in the early ureteral ligation group were 81% and 76%, and in the control group 75% and 63%, respectively (P = 0.160). In patients with renal pelvic cancer, the 1- and 2-year intravesical recurrence-free survival rates in the early ureteral ligation group were 89% and 86%, but in the control group 74% and 64%, respectively (P = 0.025). However, intravesical recurrence-free survival rates were similar in patients with ureteral cancer. Multivariate analyses of a subset of patients with renal pelvic cancer identified early ureteral ligation as an independent predictor of intravesical recurrence.
Early ureteral ligation decreases the rate of intravesical recurrence after radical nephroureterectomy in patients with renal pelvic cancer. Thus, early ureteral ligation might help in prevention of intravesical recurrence for renal pelvic cancer.
上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发率较高。上尿路尿路上皮癌细胞种植于受损膀胱壁被认为是根治性肾输尿管切除术后膀胱内复发的原因之一。我们评估了早期输尿管结扎在预防膀胱内复发中的作用。
这项前瞻性单臂临床试验纳入了2012年至2013年在东北泌尿外科循证医学研究组接受上尿路尿路上皮癌根治性肾输尿管切除术的患者。早期输尿管结扎定义为在扩大腹膜后间隙后尽快结扎输尿管。使用倾向评分匹配分析从同一组中接受根治性肾输尿管切除术的454例患者中提取历史对照。采用Kaplan-Meier曲线分析膀胱内无复发生存率。使用多因素分析评估预测膀胱内复发的因素。
74例患者接受了早期输尿管结扎。17例(23%)患者出现膀胱内复发,中位随访期为24个月。早期输尿管结扎组1年和2年膀胱内无复发生存率分别为81%和76%,对照组分别为75%和63%(P = 0.160)。在肾盂癌患者中,早期输尿管结扎组1年和2年膀胱内无复发生存率分别为89%和86%,而对照组分别为74%和64%(P = 0.025)。然而,输尿管癌患者的膀胱内无复发生存率相似。对一部分肾盂癌患者的多因素分析确定早期输尿管结扎是膀胱内复发的独立预测因素。
早期输尿管结扎可降低肾盂癌患者根治性肾输尿管切除术后膀胱内复发率。因此,早期输尿管结扎可能有助于预防肾盂癌的膀胱内复发。